WEEKLY ORAL ISLATRAVIR PROVIDES EFFECTIVE PEP AGAINST IV CHALLENGE WITH SIVMAC251

Conference Reports for NATAP

Conference on Retroviruses
and Opportunistic Infections
Boston USA
March 8-11, 2020


WEEKLY ORAL ISLATRAVIR PROVIDES EFFECTIVE PEP AGAINST IV CHALLENGE WITH SIVMAC251

	CROI 2020 March 10 Reported by Jules Levin http://www.croiwebcasts.org/console/player/44701?mediaType=slideVideo& Martin Markowitz, Agegnehu Gettie, Leslie St. Bernard, James Blanchard, Brooke Grasperge, Kerry Fillgrove, Lingling Xue, Neal Dube, Daria Hazuda, Jay Grobler